Skip to main content
Fig. 4 | Radiation Oncology

Fig. 4

From: Mono-institutional phase 2 study of innovative Stereotactic Body RadioTherapy targeting PArtial Tumor HYpoxic (SBRT-PATHY) clonogenic cells in unresectable bulky non-small cell lung cancer: profound non-targeted effects by sparing peri-tumoral immune microenvironment

Fig. 4

a, b Actuarial Kaplan-Meier cancer-specific (a) and progression-free survival (b) of 60 patients treated with three different regimens: gruop I-SBRT-PATHY, group II-CHT and group III-CONVENTIONAL PALLIATIVE RADIOTHERAPY

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us